Glenmede Trust’s Vaxxinity, Inc. Class A Common Stock VAXX Stock Holding History

Glenmede Trust’s Portfolio VAXX Stock Details VAXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-19,158	Closed	-$4.78K	–	1442
2024 Q2	$4.78K	Hold	19,158	–	–	﹤0.01%	1342
2024 Q1	$13.7K	Buy	+19,158	New	+$13.9K	﹤0.01%	1316

Glenmede Trust's VAXX Position: Q3 2024 in Review

Glenmede Trust sold out of Vaxxinity, Inc. Class A Common Stock (VAXX) in Q3 2024, closing a stake of 19,158 shares — an estimated $4.78K sold.

Glenmede Trust first reported a position in VAXX in Q1 2024 and held it in 2 quarters. The position peaked at $13.7K in Q1 2024. 0 funds tracked by Wall St. Rank hold VAXX as of Q3 2024.

Glenmede Trust reported no remaining Vaxxinity, Inc. Class A Common Stock position as of Q3 2024 after selling out during the quarter.
Glenmede Trust sold 19,158 Vaxxinity, Inc. Class A Common Stock shares in Q3 2024, an estimated $4.78K.
Glenmede Trust first reported a position in Vaxxinity, Inc. Class A Common Stock in Q1 2024 and held it in 2 quarters.
Glenmede Trust's Vaxxinity, Inc. Class A Common Stock position peaked at $13.7K in Q1 2024.
0 funds tracked by Wall St. Rank held Vaxxinity, Inc. Class A Common Stock as of Q3 2024.

Based on Glenmede Trust's 13F filing for Q3 2024, filed 13 Nov 2024.